-
Kelli D. Allen, PhD: Pain-coping skills for patients with SLE
MEET THE POSTER PRESENTER: This poster describes results of a pilot study examining the feasibility and acceptability of painTRAINER, an automated, internet-based pain coping skills training programs among individuals with lupus.
-
Sara Alehashemi, MD, MPH: Health and socioeconomic outcomes in a NOMID cohort
MEET THE POSTER PRESENTER: My poster is about the long-term outcome in patients with NOMID, managed by their local providers. Patients with NOMID present with fever, rashes, meningitis, joint pain, and dysplastic bone lesions.
-
Alia Obeidat, PhD: Mrgprd-expressing nonpeptidergic C-fibers in the mouse knee
MEET THE POSTER PRESENTER: The poster describes the anatomical distribution of The Mas-related G protein-coupled receptor D (Mrgprd)-expressing nonpeptidergic C-fibers (as subset of NaV1.8 + nociceptors) in healthy and osteoarthritis mouse knee.
-
Rheumatology’s perseverance during a pandemic will lead to a new era for the field, ACR president says
During the ACR Convergence 2020 Opening Session on Thursday, ACR President Ellen M. Gravallese, MD, talked about how the specialty’s response during the pandemic has provided great hope and will help rheumatology become an even more essential specialty.
-
Diversity resides at the core of medical excellence
Diversity is a driver of excellence in medicine, says Marc A. Nivet, EdD, MBA, but for it to be operationalized, a reboot of mindset and an upgrade in systems, structures, and policies are required.
-
Research explores role of cytokine inhibition in treatment of a spectrum of diseases
The axis of interleukin-23 (IL-23) and interleukin-17 (IL-17), which is central to the pathogenesis of spondyloarthritis, will be part of the focus of an ACR Convergence 2020 session.
-
Drug holiday may be an option for osteoporosis patients
Not all osteoporosis patients are good candidates for a drug holiday. But for some patients, a holiday reduces the risk of rare side effects along with the burdens of paying for and taking osteoporosis medications.
-
Hench Memorial Lecture to focus on the history of biologics in rheumatology
Many patients have seen biologics turn RA, psoriasis, lupus, and other familiar disorders into manageable chronic conditions with occasional flares. But the path from research to treatment is neither swift nor direct.
-
Rheumatologists have critical role in care for children with CNS dysfunction
Rheumatologists at some point may be asked to consult and evaluate children with central nervous system (CNS) dysfunction related to anautoinflammatory disease, and a session at ACR Convergence 2020 will help rheumatologists learn how to offer needed support.
-
Sasha Bernatsky, MD, PhD: Retinal toxicity of SLE patients on hydroxychloroquine
MEET THE POSTER PRESENTER: In SLE, HCQ greatly reduces lupus flares, but long term, this drug may cause irreversible retinal damage leading to vison loss, and there is no treatment for HCQ retinal toxicity other than discontinuing the drug to prevent further damage.